[Biotransformation of rifampicin in pulmonary tuberculosis patients]
- PMID: 558736
[Biotransformation of rifampicin in pulmonary tuberculosis patients]
Abstract
Biotransformation of rifampicin in 39 tuberculosis patients treated with the drug was studied. The studies showed that biotransformation of rifampicin was most intensive during the first 3--6 hours after its use, which was confirmed by excretion of maximum amounts of rifampicin and its metabolites with the urine. 2--4 weeks after the beginning of the treatment with rifampicin excretion of its metabolism products decreased. When rifampicin was used simultaneously in a single dose with tubazid excretion of rifampicin transformation product and desacetylation of the antibiotic slowed down.
Similar articles
-
[Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].Probl Tuberk. 1977 Apr;(4):61-6. Probl Tuberk. 1977. PMID: 877065 Russian. No abstract available.
-
[Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].Probl Tuberk. 1985;(4):55-7. Probl Tuberk. 1985. PMID: 4001111 Russian. No abstract available.
-
[Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].Probl Tuberk. 1980 Aug;(8):63-5. Probl Tuberk. 1980. PMID: 7403052 Russian. No abstract available.
-
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.Tubercle. 1974 Mar;55(1):81-9. Tubercle. 1974. PMID: 4620295 Review. No abstract available.
-
Clinical pharmacokinetics of rifampicin.Clin Pharmacokinet. 1978 Mar-Apr;3(2):108-27. doi: 10.2165/00003088-197803020-00002. Clin Pharmacokinet. 1978. PMID: 346286 Review.